GHRP-6 CJC-1295 no DAC Nasal Spray
GHRP-6 and CJC-1295 No DAC Nasal Spray combines GHRP-6, a synthetic growth hormone-releasing hexapeptide, with CJC-1295 No DAC (Modified GRF(1-29)), a synthetic GHRH analogue without the Drug Affinity Complex (DAC), and is available from Direct SARMs in 15 ml and 30 ml sizes.
$27.65 – $49.05Price range: $27.65 through $49.05
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought GHRP-6 CJC-1295 no DAC Nasal Spray also bought
GHRP-6 CJC-1295 no DAC Nasal Spray
GHRP-6 and CJC-1295 No DAC Blend combines two synthetic research peptides associated with distinct neuroendocrine signalling pathways. GHRP-6 is a growth hormone-releasing hexapeptide belonging to the growth hormone secretagogue class, while CJC-1295 No DAC (Modified GRF 1-29) is a synthetic growth hormone-releasing hormone (GHRH) analogue without the Drug Affinity Complex (DAC).
Direct SARMs supplies the blend as a pre-mixed aqueous nasal spray format for laboratory research, containing 2.5 mg in the 15 ml size and 5 mg in the 30 ml size. The nasal spray designation describes the physical presentation of the material and does not establish intranasal bioavailability, biological activity, synergy or suitability for administration.
Documentation includes a Certificate of Analysis (COA) and HPLC purity report to provide analytical information about the supplied material and support laboratory traceability.
GHRP-6 and CJC-1295 No DAC Blend Nasal Spray is supplied solely for laboratory research and is not intended for human or veterinary use.
Benefits of the nasal spray format
Visit the GHRP-6 Peptide Research Hub ▸
Visit the CJC-1295 no DAC Peptide Research Hub ▸
Read the GHRP-6 CJC-1295 no DAC research guide ▸
Read the GHRP-6 CJC-1295 no DAC research guide ▸
GHRP-6 CJC-1295 no DAC is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy GHRP-6 CJC-1295 no DAC Nasal Spray Luxembourg from Direct SARMS.
Additional information
| Size(s) | 15ml and 30ml |
| Amount Per Nasal | 15ml = 2.5mg (1.7mg GHRP-6 and 0.8mg CJC-1295 no DAC) | 30ml = 5mg (3.4mg GHRP-6 and 1.6mg CJC-1295 no DAC) |
| Purity | |
| Molecular Formula | C46H56N12O6 | C152H252N44O42 |
| Molecular Weight | 873.01 g/mol | 3367.9 g/mol |
| Sequence | H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Physical Form | Pre-mixed aqueous solution |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this GHRP-6 CJC-1295 no DAC compound?
The blend is supplied as a pre-mixed aqueous solution for laboratory research.
Direct SARMs supplies GHRP-6 + CJC-1295 No DAC Nasal Spray in 15 ml and 30 ml formats.
The formulation combines GHRP-6, a synthetic growth hormone-releasing hexapeptide, with CJC-1295 No DAC (Modified GRF 1-29), a synthetic GHRH analogue.
“No DAC” indicates that the GHRH analogue does not contain the Drug Affinity Complex (DAC) associated with the DAC-modified form of CJC-1295.
No. Combining the two research peptides in one formulation does not by itself establish synergy, intranasal bioavailability, biological activity, safety or efficacy.
Certificate of Analysis
| Identity | GHRP-6 CJC-1295 no DAC | CONFORMS |
| Mass (LC-MS) | 873.01 g/mol | 3367.9 g/mol | CONFORMS |
| Appearance | Pre-mixed aqueous solution | CONFORMS |







